The population of childhood cancer survivors in the U.S. is increasing, with an overall childhood cancer survival rate greater than 85% five years after diagnosis. However, survivors can still be at increased risk of various ...
Oct 2, 2023
0
58
People exposed to significant air pollution in early childhood are more likely to die early than those raised in areas with better air quality, research suggests.
Sep 19, 2023
0
41
It is a heartbreaking condition that robs children of their ability to walk, talk and recognize their loved ones and now the latest research has revealed the true impact of childhood dementia globally.
Sep 18, 2023
0
12
Three out of four children with cancer are successfully treated and survive the disease. But the treatment, which often consists of a combination of surgery, chemotherapy and radiation, can cause serious side effects and ...
Sep 11, 2023
0
14
A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children ...
Aug 28, 2023
0
1
A new measurement tool helps analyzing the survival rate of children with cancer, but also the quality of survival. Researchers at the Princess Máxima Center for Pediatric Oncology have worked with patients and survivors ...
Jun 20, 2023
0
22
Cancer is a sneaky disease. Find one method of treating it successfully, and it finds another way to survive.
May 22, 2023
0
34
Scientists at St. Jude Children's Research Hospital comprehensively characterized oncogenic fusions in pediatric cancer, providing proof-of-principle for genetic engineering-based therapies.
Apr 5, 2023
0
64
Pediatric solid tumors make up approximately 40% of all childhood cancers. While pediatric cancer is rare, children can develop a wide range of tumor types, located in different parts of the body, which can make the differential ...
Mar 3, 2023
0
43
Cancer biologists are yet to understand the mechanisms and cellular hierarchy leading to the developmental arrest in rhabdomyosarcoma (RMS)—a group of pediatric cancers, which remain enigmatic.
